Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: Clinical correlations

Journal of Urology

Volumn 155, Issue 3, 1996, Pages 999-1003

  Thrasher, J Brantley ^a   Tennant, Marie K ^b   Twomey, Patrick A ^b   Hansberry, Kurt L ^b   Wettlaufer, John N ^b   Plymate, Stephen R ^b  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

carrier proteins; prostate specific antigen; prostatic neoplasms; somatomedins; tumor markers, biological

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; TISSUE DISTRIBUTION; TRANSURETHRAL RESECTION;

EID: 0030071847     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66367-5     Document Type: Article

References (18)

1. Wingo, P. A., Tong, T. and Bolden, S.: Cancer statistics, 1995. CA, 45: 8, 1995.
2. Chung, L. W.: Fibroblasts are critical determinants in prostatic cancer growth and dissemination. Cancer Metastasis Rev., 10: 263, 1991.
3. Daughaday, W. H. and Rotwein, P.: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr. Rev., 10: 68, 1989.
4. Rotwein, P.: Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors, 5: 3, 1991.
5. Rosenfeld, R. G., Lamson, G., Pham, H., Oh, Y., Conover, C., De Leon, D. D., Donovan, S. M., Ocrant, I. and Giudice, L.: Insulin-like growth factor-binding proteins. Recent Prog. Horm. Res., 46: 99, 1990.
6. Elgin, R. G., Busby, W. H., Jr. and Clemmons, D. R.: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci., 84: 3254, 1987.
7. Cohen, P., Peehl, D. M., Lamson, G. and Rosenfeld, R. G.: Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J. Clin. Endocr. Metab., 73: 401, 1991.
8. Plymate, S. R., Ware, J. L., Tennant, M., Thrasher, J. B., Chatta, G. and Birnbaum, R. S.: Transformation and immortalization of human prostate epithelial cells alters responsiveness to insulin-like growth factor (IGF)-1 and IGF binding protein expression and secretion. Int. J. Cancer, in press.
9. Cohen, P., Peehl, D. M., Stamey, T. A., Wilson, K. F., Clemmons, D. R. and Rosenfeld, R. G.: Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J. Clin. Endocr. Metab., 76: 1031, 1993.
10. Kanety, H., Madjar, Y., Dagan, Y., Levi, J., Papa, M. Z., Pariente, C., Goldwasser, B. and Karasik, A.: Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocr. Metab., 77: 229, 1993.
11. Thrasher, J. B., Frazier, H. A., Robertson, J. E., Dodge, R. K. and Paulson, D. F.: Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer, 73: 1708, 1994.
12. Wheeler, T. M. and Lebovitz, R. M.: Fresh tissue harvest for research from prostatectomy specimens. Prostate, 25: 274, 1994.
13. Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S. and Plymate, S. R.: Comparison of insulin-like growth factor binding protein-2 and -3 mRNA and protein in normal human prostate epithelium, prostate intraepithelial neoplasia and malignant tissue. J. Clin. Endocr. Metab., in press.
14. Delhanty, P. J. D. and Han, V. K. M.: An RGD to RGE mutation in the putative membrane binding domain of insulin-like growth factor binding protein-2 inhibits its potentiation of IGF-II induced thymidine uptake by SPC cells. Read at annual meeting of Endocrine Society, p. 56, 1993.
15. Bourner, M. J., Busby, W. H., Jr., Siegel, N. R., Krivi, G. G., McCusker, R. H. and Clemmons, D. R.: Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP): comparison of its structural and functional properties with IGFBP-1. J. Cell. Biochem., 48: 215, 1992.
16. Jones, J. I., Gockerman, A., Busby, W. H., Jr., Wright, G. and Clemmons, D. R.: Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the alpha5betaN integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci., 90: 10553, 1993.
17. Cohen, P., Graves, H. C., Peehl, D. M., Kamarei, M., Giudice, L. C. and Rosenfeld, R. G.: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocr. Metab., 75: 1046, 1992.
18. Cohen, P., Peehl, D. M., Graves, H. C. and Rosenfeld, R. G.: Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocr., 142: 407, 1994.